|
Showing the most relevant articles for your search:NASDAQ:AVXS | Date | Time | Source | Headline | Symbol | Company | | 09/08/2016 | 6:05AM | Edgar (US Regulatory) | Registration of Additional Securities (up to 20%) (s-1mef) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 09/08/2016 | 6:02AM | Edgar (US Regulatory) | Post-effective Amendment Filed Solely to Add Exhibits to a Registration Statement (pos Ex) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 09/08/2016 | 6:01AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 09/07/2016 | 7:03AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 09/06/2016 | 5:23PM | Edgar (US Regulatory) | Securities Registration Statement (s-1/a) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 09/06/2016 | 4:00PM | GlobeNewswire Inc. | AveXis Announces Proposed Public Offering of 4,000,000 Shares of Common Stock | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 08/24/2016 | 5:09PM | Edgar (US Regulatory) | Securities Registration Statement (s-1) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 08/22/2016 | 6:56PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 08/12/2016 | 4:05PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 08/11/2016 | 4:09PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 08/11/2016 | 4:01PM | GlobeNewswire Inc. | AveXis Reports Second Quarter 2016 Financial and Operating Results and Interim Data from Ongoing Phase 1 Trial of AVXS-101 in... | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 08/02/2016 | 8:00AM | GlobeNewswire Inc. | AveXis to Report Second Quarter 2016 Financial and Operating Results and Interim Data from Ongoing Phase 1 Trial of AVXS-101 ... | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 07/20/2016 | 7:16AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 07/20/2016 | 7:00AM | GlobeNewswire Inc. | AveXis Receives U.S. FDA Breakthrough Therapy Designation for AVXS-101 Gene Replacement Therapy for Spinal Muscular Atrophy T... | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 07/11/2016 | 8:00AM | GlobeNewswire Inc. | AveXis Appoints Michael B. Johannesen as Senior Vice President, General Counsel and Chief Compliance Officer | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 07/07/2016 | 5:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 07/07/2016 | 5:26PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 06/24/2016 | 5:16PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 06/22/2016 | 7:31PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 06/22/2016 | 7:31PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 06/22/2016 | 7:30PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 06/22/2016 | 7:29PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 06/22/2016 | 7:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 06/06/2016 | 5:00PM | GlobeNewswire Inc. | AveXis to Present at Goldman Sachs Annual Global Healthcare Conference and Jefferies 2016 Healthcare Conference | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 05/16/2016 | 8:00AM | GlobeNewswire Inc. | AveXis Presents Pulmonary Data from Ongoing Phase 1 Trial of AVXS-101 in Spinal Muscular Atrophy Type 1 | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 05/13/2016 | 4:29PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 05/12/2016 | 4:11PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 05/12/2016 | 4:01PM | GlobeNewswire Inc. | AveXis Reports First Quarter 2016 Financial and Operating Results | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 05/06/2016 | 3:11PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 05/06/2016 | 3:10PM | GlobeNewswire Inc. | AveXis Reports Data from Ongoing Phase 1 Trial of AVXS-101 in Spinal Muscular Atrophy Type 1 | NASDAQ:AVXS | Avexis, Inc. (delisted) |
|
Showing the most relevant articles for your search:NASDAQ:AVXS |
|